Literature DB >> 9123940

Deep vein thrombosis as probable cause of fever of unknown origin.

A F Aburahma1, S Saiedy.   

Abstract

A rare patient may have fever of unknown origin (FUO) that is caused by pulmonary emboli, pelvic, or lower extremity venous thrombosis (DVT). This study reviews our experience treating patients with DVT that presented with a FUO over a two-year period. A FUO was defined as a temperature of greater than 38.4 degrees C on several occasions for at least three weeks duration that defied one week of hospital evaluation. DVT was considered as a probable cause of FUO if the following criteria were met: (1) a positive venous duplex image for acute DVT, (2) subsequent fever resolution within seven days of anticoagulation therapy. Five out of 89 patients (6%) met this criteria. Their mean age was 53 years. Four patients had iliofemoral DVT and one had femoropopliteal DVT. Two had lung scans, one was positive for pulmonary embolism, and the other was equivocal. All five patients responded to heparin therapy and their temperatures returned to normal within a few days. Venous thrombosis and/or pulmonary embolism should thus be borne in mind when patients with FUO are being evaluated.

Entities:  

Mesh:

Year:  1997        PMID: 9123940

Source DB:  PubMed          Journal:  W V Med J        ISSN: 0043-3284


  3 in total

1.  Fever six weeks after trauma.

Authors:  C J Boos; P Allen; R More; T Lancaster; M Dawes
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

2.  Fever and deep venous thrombosis. Findings from the RIETE registry.

Authors:  Raquel Barba; Pierpaolo Di Micco; Angeles Blanco-Molina; Cristina Delgado; Elena Cisneros; Jaume Villalta; María V Morales; Alessandra Bura-Riviere; Philippe Debourdeau; Manuel Monreal
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

3.  A rare case report of a saddle pulmonary embolism presenting with high grade fevers, responsive to anticoagulation.

Authors:  Muhammad Saad; Danial H Shaikh; Muhammad Adrish
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.